Pharmaceutical intermediates

Bempedoic acid Intermediates

1 pharmaceutical intermediate for Bempedoic acid. Indication: Hypercholesterolemia; Dyslipidemia; Heterozygous Familial Hypercholesterolemia (HeFH).

About Bempedoic acid

Originator: Esperion Therapeutics Inc
Indication: Hypercholesterolemia; Dyslipidemia; Heterozygous Familial Hypercholesterolemia (HeFH)
Approved Date: 02/21/2020
NCE Patent: 02/21/2025
DS/DP: 12/03/2030

1 intermediate currently listed for Bempedoic acid. Request specifications, documentation or a quotation for any item below.

Bempedoic acid intermediates
Product Name	CAS No.	Molecular Formula	Physical Properties
ethyl-2,2-dimethyl-7-bromoheptanoate	123469-92-1	/	/

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态